Brief: Sagimet Biosciences Announces Pricing Of Upsized Initial Public Offering
14/07/2023 04:01
July 13 (Reuters) - Sagimet Biosciences Inc SGMT.O :
* SAGIMET BIOSCIENCES ANNOUNCES PRICING OF UPSIZED INITIAL
PUBLIC
OFFERING
* PRICES ITS UPSIZED IPO OF 5.3 MILLION SHARES OF ITS
SERIES A
COMMON STOCK AT A AT $16.00 PER SHARE
Source text for Eikon: ID:nGNX8RHmqD
Further company coverage: SGMT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sagimet Biosciences
See all newsBrief: Sagimet Biosciences Announces Pricing Of $115.0 Million Underwritten Offering Of Series A Common Stock And Pre-Funded Warrants
Brief: Sagimet Biosciences - Suspends And Terminates ATM Prospectus Supplement For Series A Common Stock Effective Sept 30
Brief: Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial Of Denifanstat In Acne Toward Patient Enrollment In Q4 2026
Brief: Sagimet Biosciences Phase 3 Clinical Trial Is On Track To Initiate In Second Half Of 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage